Skip to content

Should we wait until sufficient good teeth brushing before periodontal treatment? A randomized clinical trial

Influence of achieving sufficient mechanical control of the supragingival biofilm before subgingival instrumentation in patients with Periodontitis: a randomized clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4pf8kms
Enrollment
Unknown
Registered
2025-10-14
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dental scaling

Interventions

This is a randomized-controlled, parallel, single-blind study. Participants will be randomly divided into two groups (n = 40) using Random Allocation Software (http://random-allocation-software.softwa

Sponsors

Universidade Estadual Paulista
Lead Sponsor
Universidade Estadual Paulista
Collaborator

Eligibility

Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: Periodontitis Stages II-IV Grades B and C, generalized: for Stages II-IV (case definition): present at least 1 tooth with at least one interproximal site with a probing depth greater than or equal to 5 mm and attachment loss greater than or equal to 4 mm. For Grade B: have a report of attachment loss of less than 2 mm in the last 5 years or have a bone loss/age percentage (of the most affected tooth) . between 0.25 and 1. For Grade C: have a report of attachment loss greater than or equal to 2 mm in the last 5 years or have a bone loss/age percentage (of the most affected tooth) greater than 1. Present a minimum of 15 teeth (excluding third molars and teeth indicated for extraction). Minimum of 6 teeth with at least 1 non-contiguous interproximal site with a probing depth greater than or equal to 5 mm and a clinical attachment level greater than or equal to 4 mm. Both sexes. Age greater than or equal to 30 years.

Exclusion criteria

Exclusion criteria: Smokers of at least 10 cigarettes/day for at least 5 years; former smokers for at least 5 years; pregnant or lactating; history of periodontal treatment in the last 6 months; continuous use of oral antiseptics; use of systemic antibiotics, corticosteroids, nonsteroidal anti-inflammatory drugs, immunosuppressants, estrogen, and estrogen receptor modulators; medications that may influence bone metabolism (alendronate, calcitonin, and others) in the last 6 months; systemic disease that may alter the host response to periodontal treatment (e.g., diabetes) or that requires prophylactic medication for dental treatment (e.g., mitral valve prolapse); use of orthodontic appliances; extensive prosthetic rehabilitation and blood dyscrasias; patients with motor limitations that have a significant impact on biofilm self-control (e.g., patients with stroke sequelae)

Design outcomes

Primary

MeasureTime frame
Reduction in probing depth - evaluate whether there is a difference between the groups regarding reduction in full-mouth probing depth at 1 year of follow-up

Secondary

MeasureTime frame
Clinical attachment gain - Evaluate whether there is a difference between the groups regarding full-mouth clinical attachment gain at 1-year follow-up

Countries

Brazil

Contacts

Public ContactEmanuel Rovai

Universidade Estadual Paulista

emanuel.rovai@unesp.br+551239479078

Outcome results

None listed

Source: REBEC (via WHO ICTRP)